Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. In March 1958, The Journal ...
OAKVILLE, ON, Sept. 25, 2012 /CNW/ - Watson Pharma Company today announced that Rapalfo® (silodosin), a new treatment for benign prostatic hyperplasia (BPH), is available in Canada. BPH is a common, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback